Sweeney Michael MD
CMO and VP, R&D at DEPOMED INC
- Sold, on record
- $348k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 2, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DEPOMED INCCMO and VP, R&D
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale DEPOMED INCUnusualJun 15, 2011 2011
Sold 5,855 shares at $8.23 ($48k)
Sweeney Michael MD, CMO and VP, R&D
Sold 76.7% of holdings ($63k position)1,778 shares leftFirst sale on recordFiling
- 2 Form 4 sale DEPOMED INCPlan not statedDec 6, 2012 +540 days
Sold 1,418 shares at $5.77 ($8k)
Sweeney Michael MD, CMO and VP, R&D
Sold 21.1% of holdings ($39k position)5,315 shares leftFiling
- 3 Form 4 sale DEPOMED INCUnusualDec 13, 2012 +7 days
Sold 43,635 shares at $5.87 ($256k)
Sweeney Michael MD, CMO and VP, R&D
Sold 96.3% of holdings ($266k position)1,680 shares leftFiling
- 4 Form 4 sale DEPOMED INCUnusualDec 2, 2013 +354 days
Sold 4,270 shares at $8.40 ($36k)
Sweeney Michael MD, CMO and VP, R&D
Sold 32% of holdings ($112k position)9,084 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2013 | Dec 4, 2013 | DEPOMED INC | CMO and VP, R&D | Form 4 sale | 4,270 | $36k | 32.0% | Unusual | SEC |
| Dec 13, 2012 | Dec 14, 2012 | DEPOMED INC | CMO and VP, R&D | Form 4 sale | 43,635 | $256k | 96.3% | Unusual | SEC |
| Dec 6, 2012 | Dec 6, 2012 | DEPOMED INC | CMO and VP, R&D | Form 4 sale | 1,418 | $8k | 21.1% | Plan not stated | SEC |
| Jun 15, 2011 | Jun 15, 2011 | DEPOMED INC | CMO and VP, R&D | Form 4 sale | 5,855 | $48k | 76.7% | Unusual | SEC |